| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 9 |
| NetGPI | no | yes: 0, no: 9 |
| Term | Name | Level | Count |
|---|---|---|---|
| GO:0005929 | cilium | 4 | 10 |
| GO:0042995 | cell projection | 2 | 10 |
| GO:0043226 | organelle | 2 | 10 |
| GO:0043227 | membrane-bounded organelle | 3 | 10 |
| GO:0110165 | cellular anatomical entity | 1 | 10 |
| GO:0120025 | plasma membrane bounded cell projection | 3 | 10 |
Related structures:
AlphaFold database: Q4Q205
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_NRD_NRD_1 | 132 | 134 | PF00675 | 0.290 |
| CLV_NRD_NRD_1 | 73 | 75 | PF00675 | 0.220 |
| CLV_PCSK_KEX2_1 | 138 | 140 | PF00082 | 0.294 |
| CLV_PCSK_PC1ET2_1 | 138 | 140 | PF00082 | 0.294 |
| CLV_PCSK_SKI1_1 | 10 | 14 | PF00082 | 0.564 |
| CLV_PCSK_SKI1_1 | 138 | 142 | PF00082 | 0.266 |
| CLV_PCSK_SKI1_1 | 203 | 207 | PF00082 | 0.593 |
| CLV_PCSK_SKI1_1 | 214 | 218 | PF00082 | 0.375 |
| CLV_PCSK_SKI1_1 | 82 | 86 | PF00082 | 0.240 |
| DEG_APCC_DBOX_1 | 213 | 221 | PF00400 | 0.515 |
| DEG_SCF_FBW7_1 | 179 | 184 | PF00400 | 0.550 |
| DOC_CDC14_PxL_1 | 87 | 95 | PF14671 | 0.427 |
| DOC_MAPK_gen_1 | 42 | 51 | PF00069 | 0.494 |
| DOC_MAPK_MEF2A_6 | 88 | 95 | PF00069 | 0.456 |
| DOC_PP1_RVXF_1 | 201 | 208 | PF00149 | 0.593 |
| DOC_USP7_MATH_1 | 163 | 167 | PF00917 | 0.687 |
| DOC_USP7_UBL2_3 | 134 | 138 | PF12436 | 0.494 |
| DOC_USP7_UBL2_3 | 15 | 19 | PF12436 | 0.438 |
| DOC_USP7_UBL2_3 | 245 | 249 | PF12436 | 0.539 |
| DOC_WW_Pin1_4 | 157 | 162 | PF00397 | 0.639 |
| DOC_WW_Pin1_4 | 169 | 174 | PF00397 | 0.555 |
| DOC_WW_Pin1_4 | 177 | 182 | PF00397 | 0.743 |
| LIG_14-3-3_CanoR_1 | 139 | 145 | PF00244 | 0.530 |
| LIG_14-3-3_CanoR_1 | 198 | 207 | PF00244 | 0.649 |
| LIG_BRCT_BRCA1_1 | 203 | 207 | PF00533 | 0.479 |
| LIG_FHA_1 | 1 | 7 | PF00498 | 0.505 |
| LIG_FHA_1 | 140 | 146 | PF00498 | 0.481 |
| LIG_FHA_1 | 190 | 196 | PF00498 | 0.763 |
| LIG_FHA_1 | 249 | 255 | PF00498 | 0.426 |
| LIG_FHA_1 | 90 | 96 | PF00498 | 0.437 |
| LIG_FHA_2 | 127 | 133 | PF00498 | 0.452 |
| LIG_FHA_2 | 142 | 148 | PF00498 | 0.507 |
| LIG_FHA_2 | 192 | 198 | PF00498 | 0.598 |
| LIG_LIR_Gen_1 | 204 | 215 | PF02991 | 0.455 |
| LIG_LIR_Nem_3 | 204 | 210 | PF02991 | 0.479 |
| LIG_MYND_3 | 43 | 47 | PF01753 | 0.478 |
| LIG_SH2_STAT5 | 253 | 256 | PF00017 | 0.451 |
| LIG_SH2_STAT5 | 72 | 75 | PF00017 | 0.422 |
| LIG_SUMO_SIM_anti_2 | 219 | 226 | PF11976 | 0.497 |
| LIG_SUMO_SIM_anti_2 | 230 | 236 | PF11976 | 0.431 |
| LIG_SUMO_SIM_anti_2 | 35 | 41 | PF11976 | 0.427 |
| LIG_SUMO_SIM_anti_2 | 92 | 97 | PF11976 | 0.456 |
| LIG_SUMO_SIM_par_1 | 216 | 222 | PF11976 | 0.462 |
| LIG_TRAF2_1 | 194 | 197 | PF00917 | 0.588 |
| LIG_UBA3_1 | 67 | 75 | PF00899 | 0.538 |
| MOD_CDC14_SPxK_1 | 172 | 175 | PF00782 | 0.582 |
| MOD_CDK_SPK_2 | 157 | 162 | PF00069 | 0.591 |
| MOD_CDK_SPxK_1 | 169 | 175 | PF00069 | 0.588 |
| MOD_CDK_SPxxK_3 | 157 | 164 | PF00069 | 0.595 |
| MOD_CK1_1 | 189 | 195 | PF00069 | 0.645 |
| MOD_CK1_1 | 201 | 207 | PF00069 | 0.504 |
| MOD_CK1_1 | 219 | 225 | PF00069 | 0.490 |
| MOD_CK2_1 | 126 | 132 | PF00069 | 0.410 |
| MOD_CK2_1 | 141 | 147 | PF00069 | 0.456 |
| MOD_CK2_1 | 191 | 197 | PF00069 | 0.726 |
| MOD_GlcNHglycan | 151 | 154 | PF01048 | 0.589 |
| MOD_GlcNHglycan | 166 | 169 | PF01048 | 0.591 |
| MOD_GSK3_1 | 13 | 20 | PF00069 | 0.451 |
| MOD_GSK3_1 | 164 | 171 | PF00069 | 0.661 |
| MOD_GSK3_1 | 177 | 184 | PF00069 | 0.657 |
| MOD_GSK3_1 | 201 | 208 | PF00069 | 0.546 |
| MOD_N-GLC_1 | 198 | 203 | PF02516 | 0.516 |
| MOD_N-GLC_1 | 54 | 59 | PF02516 | 0.294 |
| MOD_NEK2_1 | 13 | 18 | PF00069 | 0.365 |
| MOD_NEK2_1 | 149 | 154 | PF00069 | 0.524 |
| MOD_NEK2_1 | 206 | 211 | PF00069 | 0.528 |
| MOD_NEK2_1 | 216 | 221 | PF00069 | 0.483 |
| MOD_PKA_1 | 138 | 144 | PF00069 | 0.470 |
| MOD_PKA_1 | 164 | 170 | PF00069 | 0.689 |
| MOD_PKA_2 | 138 | 144 | PF00069 | 0.509 |
| MOD_Plk_1 | 225 | 231 | PF00069 | 0.446 |
| MOD_Plk_1 | 35 | 41 | PF00069 | 0.410 |
| MOD_Plk_1 | 54 | 60 | PF00069 | 0.410 |
| MOD_Plk_1 | 82 | 88 | PF00069 | 0.494 |
| MOD_Plk_4 | 216 | 222 | PF00069 | 0.406 |
| MOD_Plk_4 | 91 | 97 | PF00069 | 0.472 |
| MOD_ProDKin_1 | 157 | 163 | PF00069 | 0.638 |
| MOD_ProDKin_1 | 169 | 175 | PF00069 | 0.538 |
| MOD_ProDKin_1 | 177 | 183 | PF00069 | 0.742 |
| MOD_SUMO_rev_2 | 127 | 136 | PF00179 | 0.494 |
| TRG_DiLeu_BaEn_1 | 230 | 235 | PF01217 | 0.530 |
| TRG_ENDOCYTIC_2 | 109 | 112 | PF00928 | 0.444 |
| TRG_Pf-PMV_PEXEL_1 | 143 | 147 | PF00026 | 0.222 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P7V8 | Leptomonas seymouri | 64% | 100% |
| A0A0S4JS78 | Bodo saltans | 44% | 100% |
| A0A3S7XAD6 | Leishmania donovani | 97% | 100% |
| A4HNT1 | Leishmania braziliensis | 80% | 100% |
| A4ICR3 | Leishmania infantum | 97% | 100% |
| D0A2P1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 94% |
| E9ASJ1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
| O43822 | Homo sapiens | 33% | 100% |
| Q8C6G1 | Mus musculus | 35% | 100% |
| Q9BV99 | Homo sapiens | 32% | 100% |
| V5DRP5 | Trypanosoma cruzi | 41% | 94% |